Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00662454 · ClinicalTrials.gov registry record · Phase 4
Oral Contraceptive Efficacy and Body Weight
A Phase 4 study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- Phase 4
- Development phase
- 120
- Enrollment target
NCT00662454 is a Phase 4 study that has completed, run by Oregon Health and Science University. The registered enrollment target is 120 participants.
The verdict
NCT00662454, a Phase 4 study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 120 participants
- Enrollment target
Study Summary
The purpose of the blood spot validation portion of the study is to test if measuring female hormone levels in the blood is as accurate through a finger stick, as it is by a blood draw from a vein. The purpose of the feasibility study is to evaluate ovulation occurrence in two populations of oral contraceptive users: heavier and lighter women.
Interventions
- DRUG ethinyl estradiol / levonorgestrel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2006-01 |
| Est. Completion | 2006-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00662454
The ClinicalTrials.gov registry entry for NCT00662454 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ethinyl estradiol / levonorgestrel is the first listed.
NCT00662454 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00662454 about?
NCT00662454 is a clinical study titled "Oral Contraceptive Efficacy and Body Weight". The purpose of the blood spot validation portion of the study is to test if measuring female hormone levels in the blood is as accurate through a finger stick, as it is by a blood draw from a vein. The purpose of the feasibility study is to evaluate ovulation occurrence in two populations of oral co...
What is the current status of trial NCT00662454?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 120 participants. The study started on 2006-01. Estimated completion is 2006-05.
What interventions are being tested in trial NCT00662454?
The interventions under investigation include: ethinyl estradiol / levonorgestrel (DRUG).
Who is sponsoring clinical trial NCT00662454?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.